Product Images Cyclophosphamide

The text contains information about a medication with NDC 10019-943-25, which is cyclophosphamide 500 mg. The medication can be used for IV infusion or direct injection, with specific instructions for dissolution. It is mentioned to be a cytotoxic agent for single-dose use. The manufacturer appears to be Baxter Healthcare Corporation. Storage instructions include keeping the vial at or below 25°C (77°F).*

This is information about Cyclophosphamide for Injection, USP 500 mg/vial manufactured by Baxter Healthcare Corporation. Each vial contains 500 mg of cyclophosphamide. It must be diluted for IV infusion or direct injection use. For IV infusion, it should be added to 25 ml of sterile water for injection, USP, and shaken vigorously to dissolve the drug. For direct injection use, it should be added to 25 mL of 0.9% sodium chloride injection, USP. It should be stored at or below 25°C. This is a cytotoxic agent for single-dose use, sterile, non-pyrogenic, and for parenteral use. Detailed dosage and usage instructions should be followed to ensure safety and effectiveness.*

This is a description of Cyclophosphamide for Injection, USP 500 mg/vial manufactured by Baxter Healthcare Corporation. This medication must be diluted for IV infusion or direct injection use. The product is a single-dose vial and the text also mentions the PremierProRx trademark. Made in Germany.*

Each vial of NDG 10019-944-50 contains 1 g of cyclophosphamide for intravenous infusion. To prepare for use, add 50 mL of Cyclophosphamide Sterile Water for Injection, USP, and shake vigorously to dissolve the drug. This product is a cytotoxic agent indicated for direct infusion use. Refer to the insert for dosage and indications. Manufactured by Baxter Healthcare Corporation, the vial should be stored at or below 25°C (77°F).*

This text provides detailed information about Cyclophosphamide for Injection, USP, including dosage instructions and storage guidelines. It emphasizes the need for proper dilution before IV infusion or direct injection use, and highlights the importance of understanding the dose, indications, and toxicity of the medication. Additionally, it specifies that the product is sterile, non-pyrogenic, and for single-dose use. The text also mentions the manufacturer, Baxter Healthcare Corporation, and indicates that the product is made in Germany.*

Each vial of X101 NDG 10019-945-10 contains 2 g of cyclophosphamide. This medication is intended for IV infusion use, requiring the addition of 100 mL of sterile solution, followed by vigorous shaking for proper dissolution. It can also be used for direct injection, with the same volume of 100 mL recommended for mixing. The drug must be dissolved by vigorous shaking before administration. This cytotoxic agent is manufactured by Baxter Healthcare Corporation and should be stored at or below 25°C (77°F). For more detailed information on indications and dosage, refer to the insert included with the product.*

This text provides detailed information about Cyclophosphamide, a medication used for injection. It includes instructions for dilution for IV infusion or direct injection use, dosage details, storage information, and the manufacturer's information. It emphasizes the importance of proper knowledge of dose, indication, and toxicity before prescribing. Additionally, it states that each vial contains 2 grams of cyclophosphamide and is for single-dose use.*

This text provides information on Cyclophosphamide for Injection, USP, which comes in 2 gram/vial packaging. It must be diluted for intravenous (IV) infusion or direct injection use. The product is a single-dose vial manufactured by Baxter Healthcare Corporation in Deerfield, IL, USA. The trademark PremierProfic® is used under license by Premier Healthcare Alliance, LP. The product is made in Germany.*